Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alejandro Rodriguez-Garcia, Alejandro Babayan-Sosa, Arturo Ramirez-Miranda, Concepcion Santa Cruz-Valdes, Everardo Hernandez-Quintela, Julio C Hernandez-Camarena, Nallely Ramos-Betancourt, Regina Velasco-Ramos & Raul E Ruiz-Lozano. (2022) A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel. Clinical Ophthalmology 16, pages 1331-1355.
Read now
Read now
Anastasios G. Konstas, Antoine Labbé, Andreas Katsanos, Frances Meier-Gibbons, Murat Irkec, Konstadinos G. Boboridis, Gábor Holló, Julián García-Feijoo, Gordon N. Dutton & Christophe Baudouin. (2021) The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability. Expert Opinion on Drug Safety 20:4, pages 453-466.
Read now
Read now
Patrick Martin, Alisa Cohen, Sharif Uddin, Laura Epelbaum & Serene Josiah. (2020) Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma. Clinical Ophthalmology 14, pages 885-896.
Read now
Read now
Konstadinos G. Boboridis & Anastasios G.P. Konstas. (2018) Evaluating the novel application of cyclosporine 0.1% in ocular surface disease. Expert Opinion on Pharmacotherapy 19:9, pages 1027-1039.
Read now
Read now
Barbara Cvenkel, Špela Štunf, Irena Srebotnik Kirbiš & Margareta Strojan Fležar. (2015) Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma. Clinical Ophthalmology 9, pages 625-631.
Read now
Read now
Articles from other publishers (6)
Chiara Posarelli, Michele Figus, Gloria Roberti, Sara Giammaria, Giorgio Ghirelli, Pierpaolo Quercioli, Tommaso Micelli Ferrari, Vincenzo Pace, Leonardo Mastropasqua, Luca Agnifili, Matteo Sacchi, Gianluca Scuderi, Andrea Perdicchi, Romeo Altafini, Maurizio Uva, Dino D’Andrea, Giuseppe Covello, Maria Novella Maglionico, Antonio Maria Fea, Carmela Carnevale & Francesco Oddone. (2022) Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR). Journal of Clinical Medicine 11:18, pages 5320.
Crossref
Crossref
T. N. Malishevskaya, S. Yu. Petrov, S. M. Kosakyan & S. A. Vlasova. (2021) When is preservative-free therapy of glaucoma needed and advisable?. Russian Ophthalmological Journal 14:3, pages 25-31.
Crossref
Crossref
Chien-Chia Su, Yi-Chieh Lee & Peter Richmond Candano Lee. (2021) RETRACTED ARTICLE: Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study. Graefe's Archive for Clinical and Experimental Ophthalmology 259:5, pages 1243-1251.
Crossref
Crossref
Martina Janderová, Aleš Filouš, Martin Hložánek, Dagmar Dotřelová & Gabriela Mahelková. (2021) The Effect of Therapy on the Ocular Surface in Patients with Unilateral Paediatric Glaucoma. Czech and Slovak Ophthalmology 77:1, pages 28-34.
Crossref
Crossref
N. V. Makashova, A. E. Vasilyeva & O. Yu. Kolosova. (2020) Ocular Surface Status in Newly Diagnosed Glaucoma Cases. Ophthalmology in Russia 17:1, pages 105-110.
Crossref
Crossref
N. V. Makashova, A. E. Vasilieva & O. Yu. Kolosova. (2018) Effects of artificial tears on ocular surface in glaucomatous patients with long-term instillation of preserved antiglaucoma eye drops. Vestnik oftal'mologii 134:2, pages 59.
Crossref
Crossref